Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Accounts Payables (2016 - 2025)

Conmed (CNMD) has disclosed Accounts Payables for 16 consecutive years, with $93.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 8.41% year-over-year to $93.6 million, compared with a TTM value of $93.6 million through Dec 2025, down 8.41%, and an annual FY2025 reading of $93.6 million, down 8.41% over the prior year.
  • Accounts Payables was $93.6 million for Q4 2025 at Conmed, down from $107.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $107.1 million in Q3 2025 and bottomed at $46.6 million in Q3 2021.
  • Average Accounts Payables over 5 years is $81.9 million, with a median of $80.2 million recorded in 2023.
  • The sharpest move saw Accounts Payables dropped 18.53% in 2021, then soared 59.3% in 2022.
  • Year by year, Accounts Payables stood at $58.2 million in 2021, then increased by 26.11% to $73.4 million in 2022, then increased by 20.21% to $88.2 million in 2023, then rose by 15.9% to $102.2 million in 2024, then decreased by 8.41% to $93.6 million in 2025.
  • Business Quant data shows Accounts Payables for CNMD at $93.6 million in Q4 2025, $107.1 million in Q3 2025, and $101.1 million in Q2 2025.